FDA challenges stem cell therapy companies
Pete Shanks | Biopolitical Times | October 23, 2012
{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
GLP Podcasts & Podcast Videos | More... |
Infographics | More... |
Infographic: Could gut bacteria help us diagnose and treat diseases? This is on the horizon thanks to CRISPR gene editing
Humans are never alone. Even in a room devoid of other people, they are always in the company of billions ...
Most Popular
- Is tilapia a human-made freak that we should avoid — or an evolutionary rockstar?
- Viewpoint: Promotion of social science drivel by Science magazine editor-in-chief Holden Thorp undermines the credibility of his preeminent journal
- How prehistoric agriculture spread from the Fertile Crescent south through Africa
- Case study: Norwegians are not about to cut meat consumption to reduce the impact of climate change
- North Korea and bioweapons: US believes Communist dictatorship has engineered CRISPR biological weapons
- Missouri follows Iowa and Idaho in exploring legislation to limit lawsuits against makers of glyphosate and other pesticides deemed safe by federal government
- Were Neanderthals cannibals?
- Fabricated and plagiarized data plague scientific research — and the impacts are far-reaching and long-lasting
- Viewpoint: Uncomfortable truth — ‘Organic farming takes too much land to have any chance to feed the world in a climate-changed environment’
- Many high-functioning psychopaths live amongst us